In the newsNews in media

In the news | 9th May 2022

A legacy system approach isn’t suitable for modern BioPharma development. Here are four reasons why.

Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.

About IDBSContact us